Fruitful discussions at the Tumor-LN-oC M42 online meeting
November 26, 2024
On Monday, 25.11.24, the Tumor-LN-oC M42 consortium meeting took place online to discuss updates, progress and challenges of the last 6 months.
Meet Tumor-LN-oC at MEDICA/ COMPAMED 2024!
October 29, 2024
We’re happy to share that in an effort to share the exciting idea behind Tumor-LN-oC, as well as preliminary results of the project, Tumor-LN-oC project p
3 years behind us: Tumor-LN-oC Consortium M36 meeting in Athens
June 25, 2024
During 17-18 June 2024, the Tumor-LN-oC Consortium met in Athens for the Tumor-LN-oC Month 36 consortium meeting! With the Greek sun beaming outside, we had a f
Tumor-LN-oC Coordinator Ioanna Zergioti in panel discussion at Photonics21 Meeting
April 22, 2024
We warmly invite you to the Panel discussion during the Photonics21 Annual Meeting in Brussels where Tumor-LN-oC coordinator Ioanna Zergioti will share her insi
Tumor-LN-oC M30 Meeting in Neuchâtel
November 16, 2023
At last week’s M30 consortium meeting, Tumor-LN-oC partners presented progress in R+D activities & jointly solved challenges for the integration of all individu
Wrap-up of 2023 conference season
October 22, 2023
During the 2023 Conference season, Tumor-LN-oC partners were busy presenting their activities and progress in this interdisciplinary project! Among others, we w
M24 Meeting – Already 2 years into the project!
May 15, 2023
Last week, our consortium gathered in Turku, Finland for the Tumor-LN-oC M24 project meeting, hosted by Ã…bo Akademi University in the oldest city in Finland! T
Tumor-LN-oC is on Zenodo!
April 6, 2023
Tumor-LN-oC latest achievements, technical results and scientific outputs will be published on the Tumor-LN-oC community on Zenodo. The first two, recently pu
PhosPrint selected as finalist for the SPIE Startup Challenge
December 12, 2022
Our consortium partner PhosPrint was selected as one of the finalists of the 13th annual SPIE Startup Challenge! The final pitch presentations will take placeÂ
M18 project meeting and first successful review
December 1, 2022
After 1.5 years of project implementation, the Tumor-LN-oC consortium recently gathered in Athens for the M18 project meeting. The 2-day consortium meeting w